Zijin powder in inhibiting H22 mice solid and ascites liver cancer: experimental study / 中国中药杂志
China Journal of Chinese Materia Medica
; (24): 1346-1348, 2005.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-239681
Biblioteca responsável:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To observe the rate of Zijin powder in inhibiting H22 mice solid and ascites liver cancer and the relation between quatity and effect.</p><p><b>METHOD</b>The Kunming mics, transplanted by H22 liver cells, were divided into a model group, a cyclophosphamide group and three groups of Zijin powder in high dose, medium dose, and low dose. Then observation was made on the rate of Cancer.</p><p><b>RESULT</b>The inhibiting rates of Zijin powder of three groups (high dose group, medium dose group and low dose group) for H22 mice solid liver cancer were 30.8%, 38.31% and 48.59% respectivily. The inhibiting rates of three groups of Zijin powder (low dose group, medium dose and high dose group) for H22 mice ascites liver cancer were 6.77%, 15.59% and 14.90 % respectivily.</p><p><b>CONCLUSION</b>Zijin powder has better effect on H22 mice solid liver cancer, and its effect is greatly increasing with the increased dosage.</p>
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Farmacologia
/
Pós
/
Medicamentos de Ervas Chinesas
/
Distribuição Aleatória
/
Usos Terapêuticos
/
Relação Dose-Resposta a Droga
/
Tratamento Farmacológico
/
Neoplasias Hepáticas
/
Fitoterapia
/
Antineoplásicos Fitogênicos
Tipo de estudo:
Ensaio clínico controlado
Limite:
Animais
/
Feminino
/
Humanos
/
Masculino
Idioma:
Chinês
Revista:
China Journal of Chinese Materia Medica
Ano de publicação:
2005
Tipo de documento:
Artigo